Life Science News

Avagenesis Corp. (TSXV: VVA) has announced that it has received a Notice of Allowance from the Canadian Intellectual Property Office.

Avagenesis Corp. (TSXV: VVA) has announced that it has received a Notice of Allowance from the Canadian Intellectual Property Office.
According to the press release:
[The notice] is for a patent application on adipose cell isolation technology.  The Company anticipates the patent to be issued within 60 days.  
 
Once that occurs, patents will have been issued on the Company’s licensed technology in a total of eight jurisdictions (the others being the United States, Australia, Singapore, Russia, Japan, South Korea and China). Avagenesis expects more patent issuances internationally over the next 18 months. 

 

Featured

MARKETS

Markets
TSX20692.22-69.78
TSXV791.68-22.75
DOW33061.50+84.29
S&P 5004155.38+23.45
NASD12536.02+201.38
ASX7347.00-88.00

COMMODITIES

Commodities
Gold1859.96-3.31
Silver22.640.00
Copper4.34+0.07
Palladium2243.00+41.00
Platinum941.50+4.50
Oil105.55+0.38
Heating Oil4.25+0.05
Natural Gas7.63+0.16

DOWNLOAD FREE REPORTS

×